levormeloxifene has been researched along with Urinary Incontinence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CS; Lin, G; Lue, TF; Ning, N | 1 |
| Goldstein, SR; Nanavati, N | 1 |
| Christiansen, C; Christoffersen, C; Delmas, PD; Riis, BJ; Stakkestad, JA; Warming, L | 1 |
2 trial(s) available for levormeloxifene and Urinary Incontinence
| Article | Year |
|---|---|
Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study.
Topics: Abdominal Pain; Aged; Constipation; Endometrium; Female; Humans; Osteoporosis, Postmenopausal; Prospective Studies; Pyrrolidines; Selective Estrogen Receptor Modulators; Urinary Incontinence; Vagina | 2002 |
Adverse effects of a SERM (Levormeloxifene). Safety parameters and bone mineral density 12 months after treatment withdrawal.
Topics: Bone Density; Double-Blind Method; Endometrium; Female; Follow-Up Studies; Humans; Middle Aged; Pyrrolidines; Receptors, Estrogen; Safety; Selective Estrogen Receptor Modulators; Substance Withdrawal Syndrome; Time Factors; Urinary Incontinence; Uterine Prolapse | 2003 |
1 other study(ies) available for levormeloxifene and Urinary Incontinence
| Article | Year |
|---|---|
Effects of estrogen, raloxifene, and levormeloxifene on the expression of Rho-kinase signaling molecules in urethral smooth muscle cells.
Topics: Animals; Calcium-Binding Proteins; Calponins; Cells, Cultured; Enzyme Induction; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Regulation; Microfilament Proteins; Myocytes, Smooth Muscle; Myosin Light Chains; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Urethra; Urinary Incontinence | 2010 |